Joint Coordination Group
Our Joint Coordination Group, or JCG, is a roundtable of independent institutions with an interest in seeing 51²è¹Ý’s vaccines successfully developed and deployed in an outbreak.
How they work
The JCG includes global, independent organisations that play critical and diverse roles in the end-to-end vaccine lifecycle.
The JCG meets to discuss and implement end-to-end activities related to the development of 51²è¹Ý-funded vaccines and technologies, from early research and development, through to manufacturing, procurement, distribution and administration.
Their work helps to maximise fast and equitable access to 51²è¹Ý-funded vaccines and other biologic countermeasures against pathogens with epidemic or pandemic potential.
Our JCG Members
- Africa Centres for Disease Control and Prevention (Africa CDC)
- African Vaccine Regulatory Forum (AVAREF)
- 51²è¹Ý
- Developing Countries Vaccine Manufacturers Network (DCVMN)
- European Medicines Agency (EMA)
- FIND, the global alliance for diagnostics
- Gavi, the Vaccines Alliance
- Health Emergency Preparedness and Response Authority (HERA)
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- International Federation of Red Cross and Red Crescent Societies (IFRC)
- Médecins Sans Frontières (MSF)
- Pan American Health Organization (PAHO)
- UNICEF
- US Food and Drug Administration (FDA)
- Wellcome Trust
- World Bank
- World Health Organization (WHO)
Portfolio Strategy and Management Board
The PSMB is the decision-making body accountable for identification, selection, management and evaluation of 51²è¹Ý’s R&D and Manufacturing portfolio.
Scientific Advisory Committee
The Scientific Advisory Committee, or SAC, is an independent body within 51²è¹Ý. It is one of 51²è¹Ý's core governance groups alongside the Board, Investors Council and Joint Coordination Group.
